home / stock / repcf / repcf quote
Last: | $0.042835 |
---|---|
Change Percent: | 0.0% |
Open: | $0.042835 |
Close: | $0.042835 |
High: | $0.042835 |
Low: | $0.042835 |
Volume: | 550 |
Last Trade Date Time: | 03/15/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.042835 | $0.042835 | $0.042835 | $0.042835 | $0.042835 | 550 | 03-15-2024 |
$0.0408 | $0.0453 | $0.0408 | $0.0453 | $0.0408 | 9,974 | 03-13-2024 |
$0.04655 | $0.04655 | $0.04655 | $0.04655 | $0.04655 | 1,500 | 03-11-2024 |
$0.04015 | $0.04015 | $0.04015 | $0.04015 | $0.04015 | 433 | 03-08-2024 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.045 | 10,000 | 03-05-2024 |
$0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 17,000 | 03-04-2024 |
$0.0418 | $0.0418 | $0.0418 | $0.0418 | $0.0418 | 300 | 03-01-2024 |
$0.0398 | $0.0398 | $0.0398 | $0.0398 | $0.0398 | 50,700 | 02-28-2024 |
$0.049633 | $0.049633 | $0.049633 | $0.049633 | $0.049633 | 3,560 | 02-27-2024 |
$0.0479 | $0 | $0.0479 | $0 | $0 | 75 | 02-22-2024 |
$0.0479 | $0.0479 | $0.0479 | $0.0479 | $0.0479 | 1,456 | 02-21-2024 |
$0.0408 | $0.0445 | $0.0408 | $0.0445 | $0.0408 | 17,400 | 02-19-2024 |
$0.0408 | $0.0445 | $0.0408 | $0.0445 | $0.0408 | 17,400 | 02-16-2024 |
$0.0369 | $0.03645 | $0.0369 | $0.0369 | $0.03645 | 27,997 | 02-15-2024 |
$0.0498 | $0.0498 | $0.0498 | $0.0498 | $0.0498 | 1,000 | 02-14-2024 |
$0.0465 | $0 | $0.0465 | $0 | $0 | 6 | 02-13-2024 |
$0.0465 | $0.034 | $0.0465 | $0.0465 | $0.034 | 350 | 02-09-2024 |
$0.05045 | $0.034 | $0.05045 | $0.05045 | $0.034 | 400 | 02-08-2024 |
$0.0448 | $0.0448 | $0.0448 | $0.0448 | $0.0448 | 1,900 | 02-07-2024 |
$0.04995 | $0.04995 | $0.04995 | $0.04995 | $0.04995 | 8,000 | 02-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
RepliCel Life Sciences Company Name:
REPCF Stock Symbol:
OTCMKTS Market:
RepliCel Life Sciences Website:
New DermaPrecise™ patent application and patents granted for tendinopathy and skin rejuvenation technologies in key markets VANCOUVER, BC / ACCESSWIRE / August 4, 2022 / RepliCel Life Sciences Inc. (OTCPK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developi...
Independent Testing Performed by Innovacell Demonstrates the DermaPrecise ™ Control Leads to Unparalleled Post-Injection Cell Survival and Viability Consistency VANCOUVER, BC / ACCESSWIRE / August 2, 2022 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliC...
After over a year of pandemic-related delays, representatives of Japan's PMDA, attended at the Company's contract manufacturing facility, Innovacell, to review the manufacturing of RepliCel's NBDS cell therapy products VANCOUVER, BC / ACCESSWIRE / July 28, 2022 / RepliCel Life Sciences ...